• Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection 

      Soriano, Vicente; Ullah Nayan, Mohammad; Sillman, Brady; Hasan, Mahmudul; Deodhar, Suyash; Das, Srijanee; Sultana, Ashrafi; Thai Hoang Le, Nam; Edagwa, Benson; Gendelman, Howard E. (Advanced Drug Delivery Reviews, 2023)
      Adherence to daily oral antiretroviral therapy (ART) is a barrier to both treatment and prevention of human immunodeficiency virus (HIV) infection. To overcome limitations of life-long daily regimen adherence, longacting ...
    • Oral antivirals for the prevention and treatment of SARS-CoV-2 infection 

      Soriano, Vicente; de Mendoza, Carmen; Edagwa, Benson; Treviño, Ana; Barreiro, Pablo; Fernandez-Montero, José V.; Gendelman, Howard E. (AIDS Reviews, 2022)
      Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against severe COVID-19 disease manifestations ...
    • Ultra-long-acting (XLA) antivirals for chronic viral hepatitis 

      Soriano, Vicente ; Alvarez, Carmen ; Edagwa, Benson; de Mendoza, Carmen; Montoya, Noemí ; Treviño, Ana ; Gendelman, Howard E. (Elsevier B.V., 2022)
      Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of ...
    • Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases 

      Soriano, Vicente; Edagwa, Benson; de Mendoza, Carmen; Barreiro, Pablo; Corral, Octavio Jorge; Treviño, Ana; Gendelman, Howard E. (Future Microbiology, 07/2022)
      For two centuries, vaccines have been successful in the fight against viruses, triggering immune protection. Indeed, the elimination of smallpox, the only infectious disease eradicated to date, was made possible through ...